AGY THERAPEUTICS TO PRESENT AT J.P. MORGAN H&Q HEALTHCARE CONFERENCE

SOUTH SAN FRANCISCO, Calif. – January 3, 2002 – AGY Therapeutics, Inc. today announced that Karoly Nikolich, Ph.D., the company's chief executive officer, will present at the J.P. Morgan H&Q 20th Annual Healthcare Conference on Monday, January 7. His presentation will take place at 9:00 a.m. (PT) in the Oak Room at the Westin St. Francis Hotel in San Francisco.

About AGY Therapeutics, Inc.
AGY Therapeutics, Inc., a privately-held biotechnology company, is dedicated to discovering and developing novel treatments for central nervous system diseases, including stroke, Alzheimer's disease, depression, brain tumors and obesity. With its proprietary imAGYne platform, the company has identified and characterized a vast number of promising drug targets to treat or diagnose these diseases.
About AGY l Research & Development l Investors & Partners l AGY News l Career Opportunities l Contact Us